logo
Plus   Neg
Share
Email

Sensient Technologies Reconfirms FY20 Guidance - Quick Facts

While reporting financial results for the first quarter on Wednesday, Sensient Technologies Corp. (SXT), a maker of colors, flavors and fragrances, reconfirmed its guidance for earnings and revenue growth for the full year 2020, based upon current trends.

For fiscal 2020, the company continues to project earnings in a range of $1.85 to $2.15 per share and adjusted earnings in a range of $2.60 to $2.80 per share, which excludes divestiture & other related costs and the results of the operations to be divested as well as foreign currency headwinds.

The company also still expects low to mid-single digit revenue growth in 2020 on a local currency basis, excluding the revenues of the product lines to be divested.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.40 per share on a revenue decline of 7.9 percent to $1.22 billion for the year. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration on Saturday authorized Johnson & Johnson's (JNJ) single-dose COVID-19 vaccine for emergency use. It is the first single-shot COVID-19 vaccine and the third COVID-19 vaccine for emergency use in the U.S. - the other two being Pfizer/BioNTech's BNT162b2 and Moderna's mRNA-1273. The U.S. Food and Drug Administration said that it will rapidly work toward finalization and issuance of an emergency use authorization of Johnson & Johnson's (JNJ) single-shot COVID-19 vaccine candidate. Billionaire Warren Buffett's Berkshire Hathaway Inc. (BRK.A, BRK.B) reported that its fourth-quarter net earnings attributable to shareholders rose 23 percent to $35.84 billion from last year's $29.16 billion, with earnings per share improving to $23,015 per Class A share from $17,909 per Class A share in the prior year.
RELATED NEWS
Follow RTT